|
Q4 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|
| Assets: | |||
| Current assets: | |||
| Cash and cash equivalents | |||
| Short-term investments | |||
| Accounts receivable, net (including receivables from related parties of $270 and $279 as of March 31, 2026 and 2025, respectively) | |||
| Contract assets (including contract assets from related parties of $646 and $152 as of March 31, 2026 and 2025, respectively) | |||
| Prepaid expenses and other current assets | |||
| Total current assets | |||
| Non-current assets: | |||
| Property and equipment, net | |||
| Operating lease right-of-use assets | |||
| Finance lease right-of-use assets | |||
| Equity investments (including investments held under fair value option of $148 and $300 as of March 31, 2026 and 2025, respectively) | |||
| Goodwill | |||
| Intangible assets, net | |||
| Deferred tax assets | |||
| Non-current portion of contract assets | |||
| Other non-current assets | |||
| Total non-current assets | |||
| Total assets | |||
| Liabilities: | |||
| Current liabilities: | |||
| Accrued compensation and benefits | |||
| Tax liabilities | |||
| Contract liabilities (including contract liabilities from related parties of $36 and $81 as of March 31, 2026 and 2025, respectively) | |||
| Operating lease liabilities | |||
| Other current liabilities (including payables to related parties of $20 and $11 as of March 31, 2026 and 2025, respectively) | |||
| Total current liabilities | |||
| Non-current liabilities: | |||
| Non-current portion of accrued compensation | |||
| Deferred tax liabilities | |||
| Non-current portion of contract liabilities (including non-current portion of contract liabilities from related parties of $23 and $24 as of March 31, 2026 and 2025, respectively) | |||
| Non-current portion of operating lease liabilities | |||
| Other non-current liabilities | |||
| Total non-current liabilities | |||
| Total liabilities | |||
| Shareholders’ equity: | |||
| Ordinary shares, $0.001 par value; 1,097 shares authorized and 1,064 shares issued and outstanding as of March 31, 2026; and 1,088 shares authorized and 1,057 issued and outstanding as of March 31, 2025 | |||
| Additional paid-in capital | |||
| Accumulated other comprehensive income (loss) | |||
| Retained earnings | |||
| Total shareholders’ equity | |||
| Total liabilities and shareholders’ equity |
Loading...
